140 related articles for article (PubMed ID: 25612651)
21. GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells.
Subhash VV; Tan SH; Tan WL; Yeo MS; Xie C; Wong FY; Kiat ZY; Lim R; Yong WP
BMC Cancer; 2015 Jul; 15():550. PubMed ID: 26209226
[TBL] [Abstract][Full Text] [Related]
22. miR-320a modulates cell growth and chemosensitivity via regulating ADAM10 in gastric cancer.
Ge X; Cui H; Zhou Y; Yin D; Feng Y; Xin Q; Xu X; Liu W; Liu S; Zhang Q
Mol Med Rep; 2017 Dec; 16(6):9664-9670. PubMed ID: 29152656
[TBL] [Abstract][Full Text] [Related]
23. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.
Zhang Z; Kong Y; Yang W; Ma F; Zhang Y; Ji S; Ma EM; Liu H; Chen Y; Hua Y
Oncol Rep; 2016 Oct; 36(4):2391-7. PubMed ID: 27513895
[TBL] [Abstract][Full Text] [Related]
26. Ginkgo biloba extract enhances chemotherapy sensitivity and reverses chemoresistance through suppression of the KSR1-mediated ERK1/2 pathway in gastric cancer cells.
Liu SQ; Xu CY; Qin MB; Tan L; Zhuge CF; Mao YB; Lai MY; Huang JA
Oncol Rep; 2015 Jun; 33(6):2871-82. PubMed ID: 25962735
[TBL] [Abstract][Full Text] [Related]
27. miR-493 mediated DKK1 down-regulation confers proliferation, invasion and chemo-resistance in gastric cancer cells.
Jia X; Li N; Peng C; Deng Y; Wang J; Deng M; Lu M; Yin J; Zheng G; Liu H; He Z
Oncotarget; 2016 Feb; 7(6):7044-54. PubMed ID: 26799283
[TBL] [Abstract][Full Text] [Related]
28. Yes-associated protein enhances proliferation and attenuates sensitivity to cisplatin in human gastric cancer cells.
Lu T; Sun L; Zhu X
Biomed Pharmacother; 2018 Sep; 105():1269-1275. PubMed ID: 30021363
[TBL] [Abstract][Full Text] [Related]
29. Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2.
Zhuang M; Shi Q; Zhang X; Ding Y; Shan L; Shan X; Qian J; Zhou X; Huang Z; Zhu W; Ding Y; Cheng W; Liu P; Shu Y
Tumour Biol; 2015 Apr; 36(4):2737-45. PubMed ID: 25492481
[TBL] [Abstract][Full Text] [Related]
30. Suppression of midkine gene promotes the antitumoral effect of cisplatin on human gastric cancer cell line AGS in vitro and in vivo via the modulation of Notch signaling pathway.
Tian W; Shen J; Chen W
Oncol Rep; 2017 Aug; 38(2):745-754. PubMed ID: 28656262
[TBL] [Abstract][Full Text] [Related]
31. MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2.
Wen L; Cheng F; Zhou Y; Yin C
Saudi J Gastroenterol; 2015; 21(5):313-9. PubMed ID: 26458859
[TBL] [Abstract][Full Text] [Related]
32. MnSOD overexpression confers cisplatin resistance in lung adenocarcinoma via the NF-κB/Snail/Bcl-2 pathway.
Chen PM; Cheng YW; Wu TC; Chen CY; Lee H
Free Radic Biol Med; 2015 Feb; 79():127-37. PubMed ID: 25499851
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
[TBL] [Abstract][Full Text] [Related]
34. Melatonin Induces Cell Apoptosis in AGS Cells Through the Activation of JNK and P38 MAPK and the Suppression of Nuclear Factor-Kappa B: a Novel Therapeutic Implication for Gastric Cancer.
Li W; Fan M; Chen Y; Zhao Q; Song C; Yan Y; Jin Y; Huang Z; Lin C; Wu J
Cell Physiol Biochem; 2015; 37(6):2323-38. PubMed ID: 26645893
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.
Ge X; Liu X; Lin F; Li P; Liu K; Geng R; Dai C; Lin Y; Tang W; Wu Z; Chang J; Lu J; Li J
Oncotarget; 2016 Apr; 7(17):24466-82. PubMed ID: 27016414
[TBL] [Abstract][Full Text] [Related]
36. Conditioned medium mimicking the tumor microenvironment augments chemotherapeutic resistance via ataxia‑telangiectasia mutated and nuclear factor‑κB pathways in gastric cancer cells.
Zhuang X; Li X; Zhang J; Hu Y; Hu B; Shi Y; Sun Y; Hong G
Oncol Rep; 2018 Oct; 40(4):2334-2342. PubMed ID: 30106453
[TBL] [Abstract][Full Text] [Related]
37. Adenovirus-mediated IL-24 expression enhances the chemosensitivity of multidrug-resistantgastric cancer cells to cisplatin.
Mao Z; Bian G; Sheng W; He S; Yang J; Dong X
Oncol Rep; 2013 Nov; 30(5):2288-96. PubMed ID: 23982423
[TBL] [Abstract][Full Text] [Related]
38. CDH17 alters MMP-2 expression via canonical NF-κB signalling in human gastric cancer.
Jiang XJ; Lin J; Cai QH; Zhao JF; Zhang HJ
Gene; 2019 Jan; 682():92-100. PubMed ID: 29783070
[TBL] [Abstract][Full Text] [Related]
39. miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN.
Yang SM; Huang C; Li XF; Yu MZ; He Y; Li J
Toxicology; 2013 Apr; 306():162-8. PubMed ID: 23466500
[TBL] [Abstract][Full Text] [Related]
40. Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer.
Xiao L; Lan X; Shi X; Zhao K; Wang D; Wang X; Li F; Huang H; Liu J
Cell Death Dis; 2017 May; 8(5):e2803. PubMed ID: 28518145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
